BRCA2 carriers with male breast cancer show elevated tumour methylation

BACKGROUND: Male breast cancer (MBC) represents a poorly characterised group of tumours, the management of which is largely based on practices established for female breast cancer. However, recent studies demonstrate biological and molecular differences likely to impact on tumour behaviour and there...

Descripción completa

Detalles Bibliográficos
Autores principales: Deb, Siddhartha, Gorringe, Kylie L., Pang, Jia-Min B., Byrne, David J., Takano, Elena A., Investigators, kConFab, Dobrovic, Alexander, Fox, Stephen B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594583/
https://www.ncbi.nlm.nih.gov/pubmed/28893223
http://dx.doi.org/10.1186/s12885-017-3632-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594583/
https://www.ncbi.nlm.nih.gov/pubmed/28893223
http://dx.doi.org/10.1186/s12885-017-3632-7

Ejemplares similares